Sector Homepages

---

• 

  CBP plans rules on low-value shipments to curb fakes

  The measures would strengthen oversight of 'de minimis' shipments, known to be a route for fake goods entering the US.

• 

  USTR highlights fake pharma in Notorious Markets report

  2024 report lists 38 online and 33 physical markets accused of involvement in "substantial" counterfeiting and piracy.

• 

  Merck's 'digital twin' traceability platform comes to fruition

  M-Trust – which is now in beta test release mode – is described by the company as a "cyber-physical trust platform."

• 

  WHO warns of falsified AstraZeneca cancer drug

  The counterfeit versions of the cancer immunotherapy Imfinzi have been found in Armenia, Lebanon, and Türkiye.

• 

  ITC says CBP must crack down on illicit obesity drug imports

  Agency found that "multiple bad actors" have been importing or selling knockoff copies of Lilly's tirzepatide.

• 

  Gilead wins $31.8m damages in falsified meds case

  Defendant Lorik Papyan was earlier sentenced for unlicensed wholesale distribution of prescription drugs.

---